Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.26 USD | 0.00% | +2.03% | -7.72% |
03-21 | North American Morning Briefing : Investors -2- | DJ |
03-14 | AVROBIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.72% | 56.52M | |
+2.50% | 108B | |
+9.65% | 105B | |
+1.57% | 23.46B | |
-12.80% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.92% | 17.19B | |
+5.94% | 13.99B | |
+34.91% | 12.53B |
- Stock Market
- Equities
- AVRO Stock
- News AVROBIO, Inc.
- Wedbush Trims AVROBIO's PT to $2 From $4 on Heels of Announced Sale of Cystinosis Gene Therapy Program to Novartis, Keeps Outperform Rating